Rivaldo Heru Setiawan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rivaldo Heru Setiawan has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anatalya Diah Ayu Kumalasari
Faculty of Medicine, Universitas Diponegoro, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia 50275, Indonesia
1 shared publication - Desy Armalina
Department of Anatomy-Histology, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
1 shared publication - Gabriela Valencia Putri Husodho
Faculty of Medicine, Universitas Diponegoro, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia, Indonesia
1 shared publication - Ichsan Marzuki Prasadah
Faculty of Medicine, Universitas Diponegoro, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia 50275, Indonesia
1 shared publication - Indah Saraswati
Department of Anatomy-Histology, Faculty of Medicine, Universitas Diponegoro, Jl. Prof. Mr. Sunario, Semarang 50275
1 shared publication Najwan Muhammad Sinna
Faculty of Medicine, Universitas Diponegoro, Jl. Prof. Mr. Sunario, Semarang 50275
1 shared publication
Latest Publications
- Open Access
- 27 December 2025
- Published by Secretariat of The Indonesian Biomedical Journal in The Indonesian Biomedical Journal
- Vol. 17 (6) , 575-84
Opuntia cochenillifera Cream Accelerates Incision and Burn Wound Healing in Streptozotocin-Induced Diabetic Mice by Enhancing Fibroblast
BACKGROUND: Diabetes mellitus (DM) often leads to chronic, slow-healing wounds due to impaired tissue regeneration and sustained inflammation, which can progress to diabetic ulcers. Opuntia cochenillifera has been reported to possess antioxidant and anti-inflammatory potential, making it a promising candidate for natural wound therapies. However, standardized topical formulations and in vivo evaluations are limited. This study was conducted to develop and assess the wound-healing effects of Opuntia cochenillifera cream in diabetic mice.METHODS: Forty-eight male Balb/C mice were randomly assigned to different groups: healthy control (HC), negative control (C−), positive control (C+), and treatment (T) groups. DM was induced by a single intraperitoneal injection of 180 mg/kgBW streptozotocin. After confirming hyperglycemia, incisions and burn wounds were created and monitored for 7 and 14 days. Wound healing was assessed macroscopically (incision length, width, and burn diameter) and microscopically (fibroblast proliferation and re-epithelialization). The formulated Opuntia cochenillifera cream was evaluated for pH, homogeneity, adhesion, and spreadability using standard topical formulation tests.RESULTS: The formulated cream exhibited good homogeneity, adhesion (4.97 s), spreadability (5.10 cm), and skin-compatible pH (6.44). Phytochemical analysis confirmed the presence of flavonoids, tannins, terpenoids and alkaloids. In vivo, Opuntia cochenillifera cream significantly accelerated wound closure and increased fibroblast proliferation compared to the C− group (p<0.05). Its effects were comparable to those of the standard treatment for burn wounds and superior for incision wounds, demonstrating enhanced fibroblast activity and more organized re-epithelialization.CONCLUSION: Opuntia cochenillifera cream effectively improves wound healing in diabetic mice through the enchantment fibroblast activity and organized re-epithelialization. These findings support the potential of this formulation as a natural topical therapy for diabetic wounds, warranting further mechanistic investigation.KEYWORDS: Opuntia cochenillifera, diabetic wound, wound healing, topical cream, phytochemical
- 27 December 2025
- Published by Secretariat of The Indonesian Biomedical Journal in The Indonesian Biomedical Journal
- Vol. 17 (6) , 575-84
Open AccessOpuntia cochenillifera Cream Accelerates Incision and Burn Wound Healing in Streptozotocin-Induced Diabetic Mice by Enhancing Fibroblast
BACKGROUND: Diabetes mellitus (DM) often leads to chronic, slow-healing wounds due to impaired tissue regeneration and sustained inflammation, which can progress to diabetic ulcers. Opuntia cochenillifera has been reported to possess antioxidant and anti-inflammatory potential, making it a promising candidate for natural wound therapies. However, standardized topical formulations and in vivo evaluations are limited. This study was conducted to develop and assess the wound-healing effects of Opuntia cochenillifera cream in diabetic mice.METHODS: Forty-eight male Balb/C mice were randomly assigned to different groups: healthy control (HC), negative control (C−), positive control (C+), and treatment (T) groups. DM was induced by a single intraperitoneal injection of 180 mg/kgBW streptozotocin. After confirming hyperglycemia, incisions and burn wounds were created and monitored for 7 and 14 days. Wound healing was assessed macroscopically (incision length, width, and burn diameter) and microscopically (fibroblast proliferation and re-epithelialization). The formulated Opuntia cochenillifera cream was evaluated for pH, homogeneity, adhesion, and spreadability using standard topical formulation tests.RESULTS: The formulated cream exhibited good homogeneity, adhesion (4.97 s), spreadability (5.10 cm), and skin-compatible pH (6.44). Phytochemical analysis confirmed the presence of flavonoids, tannins, terpenoids and alkaloids. In vivo, Opuntia cochenillifera cream significantly accelerated wound closure and increased fibroblast proliferation compared to the C− group (p<0.05). Its effects were comparable to those of the standard treatment for burn wounds and superior for incision wounds, demonstrating enhanced fibroblast activity and more organized re-epithelialization.CONCLUSION: Opuntia cochenillifera cream effectively improves wound healing in diabetic mice through the enchantment fibroblast activity and organized re-epithelialization. These findings support the potential of this formulation as a natural topical therapy for diabetic wounds, warranting further mechanistic investigation.KEYWORDS: Opuntia cochenillifera, diabetic wound, wound healing, topical cream, phytochemical
- Open Access
- 15 December 2025
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Diponegoro International Medical Journal
- Vol. 6 (2) , 32-39
Prenatal–Postnatal Heavy Metal Exposure in Relation to Neurodevelopmental Disorder and ADHD: A Systematic Review
Introduction: Susceptibility to environmental insults during fetal brain development has been linked to an increased risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD). ADHD is a prevalent neurodevelopmental disorder in children and is influenced not only by genetics, but also by environmental factors, particularly prenatal exposure to heavy metals. Heavy metals, such as lead, mercury, cadmium, and arsenic, are known neurotoxins that can disrupt fetal brain development; however, evidence regarding their role in ADHD remains inconsistent.Methods: This systematic review followed PRISMA guidelines to evaluate the association between prenatal heavy metal exposure and the risk of ADHD in children. The PECO framework was used to define population, exposure, comparators, and outcomes. A comprehensive literature search was conducted across PubMed, ScienceDirect, and ProQuest, using relevant keywords. Eligible studies included human observational research (cohort, case-control, cross-sectional) between 2021 and 2025 assessing prenatal exposure to heavy metals, neurodevelopmental outcomes, and ADHD.Results: Several studies have reported that elevated prenatal levels of cadmium, lead, and manganese are associated with increased ADHD symptoms and reduced cognitive performance. The findings on mercury were mixed, potentially due to confounding factors, including fish intake and maternal nutrition. Selenium and copper demonstrate dual effects, being essential at low levels but harmful at high concentrations. Thallium exposure in the third trimester significantly impaired cognitive and psychomotor development. Some studies have highlighted sex-specific and nonlinear dose-response effects.Conclusion: Heavy metals have an inconsistent impact on neurodevelopment. While some studies have associated prenatal exposure to cadmium and lead with neurodevelopmental issues, others have not found such links. Both prenatal and postnatal exposure to heavy metals, particularly cadmium, mercury, and lead, are associated with childhood ADHD.Keywords: ADHD, prenatal exposure, heavy metals, neurodevelopment, environmental toxins
- 15 December 2025
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Diponegoro International Medical Journal
- Vol. 6 (2) , 32-39
Open AccessPrenatal–Postnatal Heavy Metal Exposure in Relation to Neurodevelopmental Disorder and ADHD: A Systematic Review
Introduction: Susceptibility to environmental insults during fetal brain development has been linked to an increased risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD). ADHD is a prevalent neurodevelopmental disorder in children and is influenced not only by genetics, but also by environmental factors, particularly prenatal exposure to heavy metals. Heavy metals, such as lead, mercury, cadmium, and arsenic, are known neurotoxins that can disrupt fetal brain development; however, evidence regarding their role in ADHD remains inconsistent.Methods: This systematic review followed PRISMA guidelines to evaluate the association between prenatal heavy metal exposure and the risk of ADHD in children. The PECO framework was used to define population, exposure, comparators, and outcomes. A comprehensive literature search was conducted across PubMed, ScienceDirect, and ProQuest, using relevant keywords. Eligible studies included human observational research (cohort, case-control, cross-sectional) between 2021 and 2025 assessing prenatal exposure to heavy metals, neurodevelopmental outcomes, and ADHD.Results: Several studies have reported that elevated prenatal levels of cadmium, lead, and manganese are associated with increased ADHD symptoms and reduced cognitive performance. The findings on mercury were mixed, potentially due to confounding factors, including fish intake and maternal nutrition. Selenium and copper demonstrate dual effects, being essential at low levels but harmful at high concentrations. Thallium exposure in the third trimester significantly impaired cognitive and psychomotor development. Some studies have highlighted sex-specific and nonlinear dose-response effects.Conclusion: Heavy metals have an inconsistent impact on neurodevelopment. While some studies have associated prenatal exposure to cadmium and lead with neurodevelopmental issues, others have not found such links. Both prenatal and postnatal exposure to heavy metals, particularly cadmium, mercury, and lead, are associated with childhood ADHD.Keywords: ADHD, prenatal exposure, heavy metals, neurodevelopment, environmental toxins
- Open Access
- 23 September 2025
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal)
- Vol. 15 (2) , 110-118
TRANSFORMING MDR-TB TREATMENT: EVIDENCE FOR SHORTER, SAFER, AND COST-SAVING REGIMENS WITH BPAL
Background: Tuberculosis (TB) remains a major global public health challenge, with multidrug-resistant TB (MDR-TB) contributing substantially to poor outcomes. Conventional regimens span 18–24 months, leading to limited adherence and treatment success. Shorter treatment regimens (STRs), such as the BPaL regimen (bedaquiline, pretomanid, and linezolid), have emerged as promising alternatives. This systematic review assessed the efficacy, safety, and economic impact of 6-month STRs for drug-resistant TB. Methods: A systematic literature review was conducted in accordance with PRISMA 2020 guidelines. PubMed and ScienceDirect were searched for studies published between 2021 and 2025. Eligible studies included clinical trials, cohort studies, and economic evaluations of regimens lasting ≤6 months. Study quality was appraised using the Joanna Briggs Institute (JBI) Critical Appraisal Tools. Results: Five studies met the inclusion criteria. BPaL regimens consistently achieved high treatment success rates (>80%), with faster sputum conversion and lower mortality compared with conventional injectable-based regimens. For example, one study in Thailand reported 82.1% favorable outcomes with BPaL versus 61–65% with standard long regimens. The all-oral BPaL regimen was generally well tolerated, with substantially fewer serious adverse events such as ototoxicity and nephrotoxicity. Economic evaluations demonstrated significant cost savings for both health systems and patients, alongside gains in disability-adjusted life years (DALYs) averted. Conclusion: Six-month, all-oral BPaL regimens are effective, safer, and more cost-efficient than conventional MDR-TB therapies. Despite challenges related to drug availability and the infrastructure needed to monitor adverse events, the evidence strongly supports their accelerated global implementation to improve MDR-TB outcomes.
- 23 September 2025
- Published by Institute of Research and Community Services Diponegoro University (LPPM UNDIP) in Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal)
- Vol. 15 (2) , 110-118
Open AccessTRANSFORMING MDR-TB TREATMENT: EVIDENCE FOR SHORTER, SAFER, AND COST-SAVING REGIMENS WITH BPAL
Background: Tuberculosis (TB) remains a major global public health challenge, with multidrug-resistant TB (MDR-TB) contributing substantially to poor outcomes. Conventional regimens span 18–24 months, leading to limited adherence and treatment success. Shorter treatment regimens (STRs), such as the BPaL regimen (bedaquiline, pretomanid, and linezolid), have emerged as promising alternatives. This systematic review assessed the efficacy, safety, and economic impact of 6-month STRs for drug-resistant TB. Methods: A systematic literature review was conducted in accordance with PRISMA 2020 guidelines. PubMed and ScienceDirect were searched for studies published between 2021 and 2025. Eligible studies included clinical trials, cohort studies, and economic evaluations of regimens lasting ≤6 months. Study quality was appraised using the Joanna Briggs Institute (JBI) Critical Appraisal Tools. Results: Five studies met the inclusion criteria. BPaL regimens consistently achieved high treatment success rates (>80%), with faster sputum conversion and lower mortality compared with conventional injectable-based regimens. For example, one study in Thailand reported 82.1% favorable outcomes with BPaL versus 61–65% with standard long regimens. The all-oral BPaL regimen was generally well tolerated, with substantially fewer serious adverse events such as ototoxicity and nephrotoxicity. Economic evaluations demonstrated significant cost savings for both health systems and patients, alongside gains in disability-adjusted life years (DALYs) averted. Conclusion: Six-month, all-oral BPaL regimens are effective, safer, and more cost-efficient than conventional MDR-TB therapies. Despite challenges related to drug availability and the infrastructure needed to monitor adverse events, the evidence strongly supports their accelerated global implementation to improve MDR-TB outcomes.